Destination LVAD National Coverage Determination Referred To MCAC

Thoratec anticipates Medicare coverage of the HeartMate VE left-ventricular assist device as "destination therapy" in 2003, despite CMS' Oct. 30 announcement that it has referred the procedure to the Medicare Coverage Advisory Committee